References
- Bandyk D, Esses GE. Prosthetic graft infection. Surg Clin N Am 1994; 74: 571–590.
- Kaise A, Clayson K, Mulherin J. Antibiotic prophylaxis invascular surgery. Ann Surg 1978; 188: 283–289.
- Pitt H, Postier R, MacGowan W et al. Prophylactic antibiotics in vascular surgery. Ann Surg 1980; 192: 356–364.
- Salzmann G. Perioperative infection prophylaxis in vas-cular surgery. A randomised prospective study. Thoracic Cardiovasc Surg 1983; 31: 239–242.
- Hasselgren P, Ivarsson L, Seeman T. Effects of prophy-lactic antibiotics in vascular surgery. Ann Surg 1984; 200: 86–92.
- Bennion R. Hiatt J, Williams R et al. A randomised prospective study of perioperative microbial prophylaxis for vascular surgery. J Cardiovascular Surg 1985; 26: 270–274.
- Robbs J, Reddy E, Ray R. Antibiotic prophylaxis in aor-tic and peripheral arterial surgery in the presence of infected extremity lesions. Drugs 1988; 35 (suppl): 141-150.
- Mini E, Nobili S, Periti P. Methicillin-resistant staphylo-cocci in clean surgery. Is there a role for prophylaxis? Drugs 1997; 6: 39–52.
- Marroni M, Cao P, Fiorio M, Magrini M, Lenti M, Repetto A, Menichetti F. Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery. Eur J Clin Microbiol Infect Dis 1999; 3: 175–8.
- Kester RC, Antrum R, Thornton CA, Ramsden CH, Harding I. A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. J Hosp Infect 1999; 3: 233–43.
- Risberg B, Drott C, Dalman P, et al. Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postop-erative infection in vascular surgery: a randomised double-blind,prospective multicentre study. Eur J Vasc Endovasc Surg 1995; 10: 346–51.
- Ghiselli R, Giacometti A, Goffi L, et al. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. Eur J Vasc Endovasc Surg 2000; 20: 508–11.
- McManus AT, Goodwin CW, Pruitt BAJr. Observations on the risk of resistence with the extended use of vancomycin. Arch Surg 1998; 133: 1207–1211.
- Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24 (suppl 1): S67-S73.
- Hall JC, Christiansen KJ, Goodman M, et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg 1998; 175: 87–90.
- McDonald M, Grabsch E, Marhall C, Forbes A. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 1998; 68: 388–96.
- Gathan V, Esses GE, Bandyk DF et al. Antistaphylococcal activity of rifampicin-bonded gelatin-impregnated Dacron grafts. J Surg Res 1995; 58: 105–110.
- D'Addato M, Curti T, Freyrie A, Agus GB, Bertini D, Biasi G. Prevention of early graft infection with rifampicin-bonded Gelseal grafts: a multicentrici experimental study. Cardiovasc Surg 1994; 2: 254–8.
- D'Addato M, Curti T, Freyrie A. Prophylaxis of graft infection with rifampicin bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Italian Investigators Group. Cardiovasc Surg 1996; 4: 200–204.
- D'Addato M, Curti T, Freyrie A. The rifampicin-bonded Gelseal graft. Eur J Endovasc Surg 1997; 14 (suppl A): 15-17.
- Earnshaw JJ, Whitman B, Heather BP on behalf of the joint Vascular Research Group. Two-year results of a ran-domised controlled trial of rifampicin-bonded extra-anatomic Dacron grafts. Br J Surg 2000; 87: 758–759.
- Strachan CJL, Newsome SWB, Ashton TR. The clini-cal use of an anitibiotic bonded graft. Eur J Vasc Surg 1991; 5: 627–632.
- Haverich A, Stephan H, Karck M et al. Prevention of graft infection by bonding of gentamicin to Dacron prosthesis. J Vasc Surg 1992; 15: 187–193.
- Williams RL, Williams DF. The biocompatibility of sil-ver. Crit Rev Biocompat 1989; 5: 221–44.
- Hernandez-Richter T, Schardey HM, Löhlein F, et al. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. Eur J Vasc Endovasc Surg 2000; 20: 413–418.
- Monouguian S. Our clinical experience with new antimicrobial coated Inter Gard-IGK/AM-vascular graft in the surgical treatment of deep wound infections involving the allo-plastic by-pass: report about two cases. Zentralbl Chir 1996; 11: 768–772.
- Regös J, Zak O, Solf R, Vischer WA, Weirich EG. Antimicrobial spectrum of Triclosan, a broad-spectrum antimi-crobial agent for topical application. Dermatologica 1979; 158: 72–79.
- Speziale F, Rizzo L, Sbarigia E, et al. Bacterial and clinical criteria relating to the outcome of patients undergo replacement of infected abdominal aortic grafts. Eur J Vasc Endovasc Surg 1997; 13 (2): 127–33.
- Thaller MC, SeIan L, Fiorani P, Passariello C, Rizzo L, Speziale F. A comparative in vitro evaluation of different ther-apeutic protocols for infections. Eur J Vasc Endovasc Surg 1997; 14 (suppl A): 35-7.
- Fiorani P, Fiorani F, Rizzo L, Taurino M, Giannoni MF, Lauri D. Long-term follow-up after in situ graft replacement in patients with aortic infections. Eur J Vasc Endovasc Surg 1997; 14 (suppl A): 111-4.
- Earnshaw JJ. The current role of Rifampicin-impregnat-ed grafts: pragmatism versus science. Eur J Vasc Endovasc Surg 2000; 20: 409–412.
- Benaerts PJ, Ridler BM, Vercaeren P, Thompson JF, Campbell WB. Gentamicin beads in vascular surgery: long-term results of implantation. Cardiovasc Surg 1999: 7: 447–50.
- Platt R. Antibiotic prophylaxis in clean surgery: does it work? Should it be used if it does? New Horizons 1998: 6: 53–7.